Large study looks at how a 25-Gene cancer test affects patients and families
NCT ID NCT02324062
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a genetic test that checks 25 genes linked to hereditary cancers is used in clinics. Over 1,500 people with a personal or family history of cancer took part. Researchers collected blood samples and had participants fill out questionnaires over five years to learn about their experiences and how the test results affected their care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATAXIA TELANGIECTASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stanford University
Stanford, California, 94305, United States
-
University of Southern California/ Kenneth Norris, Jr. Comprehensive Cancer Center and Hospital
Los Angeles, California, 90089-9181, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a freezing balloon zap away precancerous gut growths?
- Beyond BRCA: new gene panel could sharpen cancer risk prediction
- Can a walking routine alter cancer biomarkers? new trial investigates
- Could early markers unlock treatments for a rare childhood disease?
- Digital assistant aims to close gaps in hereditary cancer care
- Lynch syndrome patients share colonoscopy struggles in new survey